Most recent

PDA TR 13-2-2020

Fundamentals of an Environmental Monitoring Program Annex 1: Environmental Monitoring of Facilities Manufacturing Low Bioburden Products

This addendum complements the existing PDA TR-13 and is not meant to change or modify its content. The addendum provides recommendations for the development of an environmental control and monitoring program for classified areas and the associated GMP processes used for manufacturing operations requiring bioburden control in the biotechnology and pharmaceutical industries. The content includes a review of regulatory requirements and the development of risk assessments based on the criticality and complexity of processes, as well as industry examples of these risk-based approaches.

CONTENT PROVIDER
Parenteral Drug Association [pda]

Others Also Bought
Bioburden and Biofilm Management in Pharmaceutical Manufacturing Operations
Points to Consider for Cleaning Validation
Fundamentals of an Environmental Monitoring Program
Included in Packages
This standard is not included in any packages.
Document History
Revises:
Amendments & Corrections
We have no amendments or corrections for this standard.